AU8856298A - Partially hydrogenated polycyclic compounds - Google Patents

Partially hydrogenated polycyclic compounds

Info

Publication number
AU8856298A
AU8856298A AU88562/98A AU8856298A AU8856298A AU 8856298 A AU8856298 A AU 8856298A AU 88562/98 A AU88562/98 A AU 88562/98A AU 8856298 A AU8856298 A AU 8856298A AU 8856298 A AU8856298 A AU 8856298A
Authority
AU
Australia
Prior art keywords
partially hydrogenated
polycyclic compounds
hydrogenated polycyclic
compounds
partially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU88562/98A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU8856298A publication Critical patent/AU8856298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044Pyrrole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
AU88562/98A 1997-07-07 1998-07-03 Partially hydrogenated polycyclic compounds Abandoned AU8856298A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH1646/97 1997-07-07
CH164697 1997-07-07
CH2145/97 1997-09-11
CH214597 1997-09-11
PCT/EP1998/004141 WO1999002532A2 (fr) 1997-07-07 1998-07-03 Composes polycycliques partiellement hydrogenes

Publications (1)

Publication Number Publication Date
AU8856298A true AU8856298A (en) 1999-02-08

Family

ID=25688257

Family Applications (1)

Application Number Title Priority Date Filing Date
AU88562/98A Abandoned AU8856298A (en) 1997-07-07 1998-07-03 Partially hydrogenated polycyclic compounds

Country Status (4)

Country Link
AU (1) AU8856298A (fr)
CO (1) CO4940430A1 (fr)
PE (1) PE84299A1 (fr)
WO (1) WO1999002532A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19917990A1 (de) * 1999-04-20 2000-11-02 Florian Lang Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk
AU6014900A (en) 1999-07-13 2001-01-30 Kyowa Hakko Kogyo Co. Ltd. Staurosporin derivatives
FR2801054B1 (fr) * 1999-11-17 2003-06-13 Adir Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10042137A1 (de) * 2000-08-28 2002-03-14 Florian Lang sgk2 und sgk3 als diagnostische und therapeutische Targets
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) * 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
ATE369894T1 (de) * 2000-11-22 2007-09-15 Novartis Pharma Gmbh Kombination enthaltend ein mittel zur verminderung von vegf-aktivität und ein mittel zur verminderung von egf-aktivität
SK12022003A3 (sk) 2001-03-22 2004-05-04 Bristol-Myers Squibb Company Na topoizomerázu I selektívne cytotoxické cukrové deriváty indolpyrolkarbazolov
EP1439863B1 (fr) 2001-10-29 2011-01-12 Boehringer Ingelheim International GmbH Proteines homologues de mnk kinase impliquees dans la regulation de l'homeostase energetique et du metabolisme des organites
RU2337692C3 (ru) 2001-10-30 2020-11-09 Новартис Аг Производные стауроспорина в качестве ингибиторов активности рецепторной тирозинкиназы flt3
CA2478473A1 (fr) * 2002-01-25 2004-09-02 Pharmacia Corporation Therapie anti-aldosterones permettant de prevenir ou de traiter des troubles associes a une inflammation
WO2005014004A1 (fr) 2003-08-08 2005-02-17 Novartis Ag Combinaisons contenant des staurosporines
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
CN102101866A (zh) * 2010-11-04 2011-06-22 中国海洋大学 十字孢碱卤代衍生物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
EP0703917A1 (fr) * 1993-06-17 1996-04-03 Novartis AG Compose d'indolocarbazole utilise comme inhibiteur de proteine-kinase c
EP0763042A1 (fr) * 1994-06-01 1997-03-19 Novartis AG Derives de lactame polycyclique destines a sensibiliser a des agents antitumoraux des cellules a resistance multiple aux anticancereux
WO1997007081A2 (fr) * 1995-08-11 1997-02-27 Yale University Synthese d'indolocarbazols glycosyles

Also Published As

Publication number Publication date
WO1999002532A3 (fr) 1999-04-01
WO1999002532A2 (fr) 1999-01-21
CO4940430A1 (es) 2000-07-24
PE84299A1 (es) 1999-09-09

Similar Documents

Publication Publication Date Title
AU5703398A (en) Novel compounds
AU7210598A (en) Novel compounds
AU6804098A (en) Triazinylaminostilbene compounds
AU8856298A (en) Partially hydrogenated polycyclic compounds
AU5335798A (en) Stomatic composition
AU8747498A (en) Food-preservative composition
AU6827898A (en) Detergent-package combination
AU4925697A (en) Compounds
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU1277799A (en) Polycyclic alpha-amino-$m(e)-caprolactams and related compounds
AUPO941497A0 (en) Novel compounds
AU8121998A (en) Composition
AUPP042397A0 (en) 5-arylpyrazole compounds
AU7124598A (en) Polymer-platinum compounds
AU5423298A (en) Novel compounds
AUPO062696A0 (en) Novel compounds
AU1098499A (en) Emulsifier-lipid composition
AU8019998A (en) Fluoromethoximino compounds
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AU7702796A (en) Polycyclic compounds
AU7041098A (en) Pi-complex compounds
AU9753998A (en) Azaboroxine compounds
AU6128398A (en) New composition
AU4641497A (en) Novel compounds
AU1334399A (en) Tricyclic 3-oxo-propanenitrile compounds